Atlas Trials

Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

Clinical trial NCT01280747 · TERMINATED

Trial details

NCT number
NCT01280747
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
TERMINATED
Study type
OBSERVATIONAL
FibromyalgiaPainful Diabetic Peripheral Neuropathy
Start date
2011-01-01
Primary completion
2012-04-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.